2.30
-0.05 (-2.26%)
| Previous Close | 2.35 |
| Open | 2.31 |
| Volume | 25,507 |
| Avg. Volume (3M) | 102,892 |
| Market Cap | 1,498,178,560 |
| 52 Weeks Range | |
| Earnings Date | 30 Jul 2025 |
| Profit Margin | -142.87% |
| Operating Margin (TTM) | -37.77% |
| Diluted EPS (TTM) | -4.26 |
| Quarterly Revenue Growth (YOY) | 485.40% |
| Quarterly Earnings Growth (YOY) | 111.40% |
| Current Ratio (MRQ) | 0.570 |
| Operating Cash Flow (TTM) | -312.60 M |
| Levered Free Cash Flow (TTM) | -241.91 M |
| Return on Assets (TTM) | -26.87% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (GB) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | IDORSIA LTD IDORSIA N ORD SHS | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | -1.63 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| IDORSIA LTD IDORSIA N ORD SHS | 1 B | - | - | - |
| ARROWHEAD PHARMACEUTICALS INC A | 2 B | - | - | - |
| RELIEF THERAPEUTICS HOLDING SA | 2 B | - | - | - |
| OXFORD NANOPORE TECHNOLOGIES PL | 1 B | - | - | 2.97 |
| BASILEA PHARMACEUTICA AG BASILE | 560 M | - | - | - |
| IOVANCE BIOTHERAPEUTICS INC IOV | 401 M | - | - | - |
|
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 30.75% |
| % Held by Institutions | 15.64% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |